Causes of death in the ATLAS study: effects of high-dose ACE inhibitors
Cleland, J.G.
International Journal of Clinical Practice. Suppl 100: 19-20
1999
ISSN/ISBN: 1368-504X PMID: 10658295 Document Number: 510381
Document emailed within 1 workday
Related Documents
Kraus, W. 1997: Glücksspiel und Frauen im Hohen Atlas : Zur ethnographischen Quellenkritik - Game of chance and women in High Atlas : criticism of ethnographical sources - Jeu de hasard et femmes dans le Haut-Atlas : critique des sources ethnographiques Mitteilungen der Anthropologischen Gesellschaft in Wien 127: 99-109Chevallier, B. 1990: Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S33-S36
Michel Cabouret 2000: Le centenaire du premier atlas national au monde : l'Atlas de Finlande / The centenary of the world's first national atlas : Atlas of Finland Annales de Géographie 109(612): 172-175
Michel Cabouret 2000: Le centenaire du premier atlas national au monde : l'Atlas de Finlande / The centenary of the world's first national atlas : Atlas of Finland Annales de Géographie 109(612): 172-175
Michel Cabouret 2000: Le centenaire du premier atlas national au monde : l'Atlas de Finlande / The centenary of the world's first national atlas : Atlas of Finland Annales de Géographie 109(612): 172-175
Michel Cabouret 2000: Le centenaire du premier atlas national au monde : l'Atlas de Finlande / The centenary of the world's first national atlas : Atlas of Finland Annales de Géographie 109(612): 172-175
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Lala, A.; Berger, J.S. 2011: Percutaneous coronary intervention for acute coronary syndromes: no difference in 30-day efficacy or safety of high- and low-dose aspirin; double-dose clopidogrel reduces 30-day risk of cardiovascular death, myocardial infarction or stroke compared with standard dose but increases risk of major bleeding Evidence-Based Medicine 16(3): 80-81
Garrido, G.; Bretó, M.; Pérez, F.; Berenguer, J. 1983: Comparative study of the effects of an average dose of chenodesoxycholic acid and a high dose of ursodesoxycholic acid (dosage equivalents: 15 mg/kg/day) on the composition of lipids and bile acids in the bile of patients with radiotransparent biliary lithiasis Revista Clinica Espanola 170(1-2): 31-36
El Khalki, Y.; Hafid, A. 2002: Turbidité, indicateur du fonctionnement perturbé du géosystème kartstique de l'Atlas de Beni Mellal (Moyen Atlas méridional, Maroc) - Turbidity, as an indicator of perturbed functioning of Beni Mellal Atlas karstic geosystem (southern Middle Atlas, Morocco) Karstologia (40): 39-44
Capizzi, R.L.; Yang, J.L.; Rathmell, J.P.; White, J.C.; Cheng, E.; Cheng, Y.C.; Kute, T. 1985: Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation Seminars in Oncology 12(2 Suppl 3: 65-74
Schneider, W.; Bussmann, W.D.; Stahl, B.; Wietschoreck, A.; Kaltenbach, M. 1985: The antianginal efficacy of isosorbide dinitrate: dose-response relation and long-term effects of high-dose treatment Zeitschrift für Kardiologie 74(Suppl 1): 55-63
Marciani, M.G.; Cianciulli, P.; Stefani, N.; Stefanini, F.; Peroni, L.; Sabbadini, M.; Maschio, M.; Trua, G.; Papa, G. 1991: Toxic effects of high-dose deferoxamine treatment in patients with iron overload: an electrophysiological study of cerebral and visual function Haematologica 76(2): 131-134
Häcker, G.; Hawkins, C.J.; Smith, K.G.; Vaux, D.L. 1996: Effects of viral inhibitors of apoptosis in models of mammalian cell death Behring Institute Mitteilungen 97: 118-126
Matthee, R. 2008: Atlas Historique du Golfe Persique (XVIe-XVIIIe siècles) / Historical Atlas of the Persian Gulf (Sixteenth to Eighteenth Centuries) / Atlas-i tarikhi-yi Khalij-i Fars (Qarn-i shansdihum-qarn-i hizhdihum) Journal of the Economic and Social History of the Orient 51(3): 518-521
Knauer, R.H. 1998: National health insurance refused high dose chemotherapy. "Death sentence" based on financial considerations? Fortschritte der Medizin 116(20-21): 48-49
Lissoni, P.; Brivio, F.; Brivio, O.; Fumagalli, L.; Gramazio, F.; Rossi, M.; Emanuelli, G.; Alderi, G.; Lavorato, F. 1995: Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients Journal of Biological Regulators and Homeostatic Agents 9(1): 31-33
Ersmark, H.; Kalen, R. 1987: Injuries of the atlas and axis. a follow-up study of 85 axis and 10 atlas fractures Clinical Orthopaedics and Related Research 217: 257-260
Littlefield, N.A.; Farmer, J.H.; Gaylor, D.W.; Sheldon, W.G. 1980: Effects of dose and time in a long-term, low-dose carcinogenic study Journal of Environmental Pathology and Toxicology 3(Special Issue 3): 17-34
Ohtake, T.; Yasuda, M.; Watanabe, K.; Ito, T.; Ito, J.; Miyamoto, K.; Yoshida, S.; Abe, N.; Ishigame, T.; Ishii, M.; Kimijima, I.; Takenoshita, S. 2009: Efficacy and safety of high-dose toremifene for hormone-responsive advanced or metastatic breast cancer patients with failed prior treatment by aromatase inhibitors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1459-1463